Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05935098
Title A Study of BGB-A3055, Alone and in Combination With Tislelizumab in Participants With Selected Advanced or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BeiGene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | AUS

Facility Status City State Zip Country Details
University of Iowa Hospitals and Clinics RECRUITING Iowa City Iowa 52242 United States Details
John Theurer Cancer Center Hackensack University Medical Center RECRUITING Hackensack New Jersey 07601 United States Details
Next Dallas RECRUITING Irving Texas 75039 United States Details
Chris Obrien Lifehouse RECRUITING Camperdown New South Wales 2050 Australia Details
Icon Cancer Centre South Brisbane RECRUITING South Brisbane Queensland 4101 Australia Details
Linear Clinical Research RECRUITING Nedlands Western Australia 6009 Australia Details
Chongqing University Cancer Hospital RECRUITING Chongqing Chongqing 400030 China Details
Fujian Cancer Hospital RECRUITING Fuzhou Fujian 350014 China Details
Liaoning Cancer Hospital and Institute RECRUITING Shenyang Liaoning 110042 China Details
Tianjin Medical University Cancer Institute and Hospital RECRUITING Tianjin Tianjin 300060 China Details
Centre de Lutte Contre Le Cancer Institut Bergonie RECRUITING Bordeaux 33076 France Details
Institut Curie RECRUITING Paris 75005 France Details
Ico Site Rene Gauducheau RECRUITING SaintHerblain 44805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field